Sino Biopharmaceutical Ltd.

65
Hold
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG8167W1380
HKD
6.80
0.07 (1.04%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Sino Biopharmaceutical Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
5,850.00
6,558.00
6,242.00
5,956.00
5,636.00
6,326.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
108.00
-475.00
-227.00
-408.00
293.00
-320.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
9,057.00
7,307.00
8,511.00
11,635.00
6,312.00
6,271.00
Cash Flow from Investing Activities
-3,976.00
-1,972.00
-6,328.00
-8,247.00
-9,365.00
-4,922.00
Cash Flow from Financing Activities
-6,609.00
-6,705.00
-3,337.00
-3,839.00
2,730.00
3,528.00
Net Cash Inflow / Outflow
-1,380.00
-1,270.00
-1,098.00
-1,234.00
-7.00
4,984.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
146.00
100.00
55.00
-783.00
314.00
107.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Sino Biopharmaceutical Ltd.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Profit Before Tax
5850.21923002208
-40.7798271642751
5,890.00
14445.87%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
108.247824212234
437.76079753036
-329.00
-75.27%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
9057.93666859033
1978.77681867259
7,079.00
357.75%
Cash Flow from Investing Activities
-3976.60345027409
-2763.53586742958
-1,213.00
-43.90%
Cash Flow from Financing Activities
-6609.10436100462
-524.988774107523
-6,085.00
-1158.90%
Net Cash Inflow / Outflow
-1380.84038022312
-1295.99769609388
-85.00
-6.55%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
146.930762465262
13.7501267706407
133.00
968.58%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is 23.95% vs -14.15% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
9,057.94
7,307.56
23.95%